Oric Pharmaceuticals, Inc.2024财年实现净利润-1.28亿美元，同比减少26.73%

市场透视2025-02-22

2月22日，Oric Pharmaceuticals, Inc.（ORIC.US）公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.（ORIC.US）总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2513929822?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-22 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2513929822","market":"us","top_or_hot":-1,"title":"Oric Pharmaceuticals, Inc.2024财年实现净利润-1.28亿美元，同比减少26.73%","media":"市场透视","content":"<div>\n<p>2月22日，Oric Pharmaceuticals, Inc.（ORIC.US）公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.（ORIC.US）总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oric Pharmaceuticals, Inc.2024财年实现净利润-1.28亿美元，同比减少26.73%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOric Pharmaceuticals, Inc.2024财年实现净利润-1.28亿美元，同比减少26.73%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-22 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月22日，Oric Pharmaceuticals, Inc.（ORIC.US）公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.（ORIC.US）总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORIC","symbol_name":"Oric Pharmaceuticals Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b","article_id":"2513929822","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222000131abd7c349&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2513929822","pubTimestamp":1740153658,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2月22日，Oric Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为0.11。机构评级：截至2025年2月22日，当前有11家机构对Oric Pharmaceuticals, Inc.目标价做出预测，其中目标均价为19.27美元，其中最低目标价为13.00美元，最高目标价为25.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"ORIC":"Oric Pharmaceuticals Inc."},"translate_title":"Oric Pharmaceuticals, Inc. achieved net profit of-$128 million in fiscal 2024, a year-on-year decrease of 26.73%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORIC":0.9},"content_text":"2月22日，Oric Pharmaceuticals, Inc.（ORIC.US）公布财报，公告显示公司2024财年净利润为-1.28亿美元，同比减少26.73%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Oric Pharmaceuticals, Inc.（ORIC.US）总负债33.61百万美元，其中短期债务3.18百万美元，资产负债比为0.09，流动比率为0.11。机构评级：截至2025年2月22日，当前有11家机构对Oric Pharmaceuticals, Inc.目标价做出预测，其中目标均价为19.27美元，其中最低目标价为13.00美元，最高目标价为25.00美元。公司简介：ORIC Pharmaceuticals Inc 是一家临床阶段的生物制药公司。 它拥有一系列旨在通过利用其在三个特定领域的专业知识来对抗癌症耐药机制的疗法：激素依赖性癌症、精准肿瘤学和关键肿瘤依赖性。 公司拥有在研产品ORIC-944、ORIC-114、ORIC-533。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2513929822","isCrawlerRequest":true}